CD56+ NK cells from patients with non–small cell lung cancer (NSCLC) or squamous cell carcinoma (SCC) showed enhanced production of vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) (108). Here, VEGFA is linked to lung cancer.